BOK Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $283 | Hold |
|
|||||
|
2024
Q4 | $270 | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $30.9K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $32.5K | Sell |
|
|||||
|
2023
Q1 | $67.1K | Buy |
|
|||||
|
2021
Q1 | $1.07M | Buy |
|
|||||
|
2020
Q4 | $1.22M | Buy |
|
|||||
|
2020
Q3 | $951K | Sell |
|
|||||
|
2020
Q2 | $2.27M | Buy |
|
|||||
|
2020
Q1 | $1.46M | Sell |
|
|||||
|
2019
Q4 | $1.92M | Sell |
|
|||||
|
2019
Q3 | $2.24M | Buy |
|
|||||
|
2019
Q2 | $2.71M | Sell |
|
|||||
|
2019
Q1 | $3.81M | Buy |
|
|||||
|
2018
Q4 | $2.92M | Sell |
|
|||||
|
2018
Q3 | $4.31M | Buy |
|
|||||
|
2018
Q2 | $1.38M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $1.84M | Sell |
|
|||||
|
2017
Q1 | $2.14M | Sell |
|
|||||
|
2016
Q4 | $2.96M | Buy |
|
|||||
|
2016
Q3 | $2.56M | Sell |
|
|||||
|
2016
Q2 | $2.3M | Buy |
|
|||||
|
2016
Q1 | $1.18M | Sell |
|
|||||
|
2015
Q4 | $2.22M | Sell |
|
|||||
|
2015
Q3 | $2.25M | Sell |
|
|||||
|
2015
Q2 | $3.67M | Buy |
|
|||||
|
2015
Q1 | $3.18M | Buy |
|
|||||
|
2014
Q4 | $1.93M | Sell |
|
|||||
|
2014
Q3 | $2.49M | Sell |
|
|||||
|
2014
Q2 | $2.55M | Buy |
|
|||||
|
2014
Q1 | $2.15M | Buy |
|
|||||
|
2013
Q4 | $2.21M | Buy |
|